Intuit, Hewlett Packard Enterprise And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Dow Dips Around 500 Points, Market Volatility Increases Further
US stocks recorded sharp losses on Monday as investors were concerned that China's strict Covid-19 policies would negatively impact economic growth around the world.
Dow Tumbles 450 Points; S&P 500 Falls 1.5%
U.S. stocks traded lower toward the end of trading amid protests over COVID-19 restrictions in China. The Dow Jones dropped more than 450 points on Monday.
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
Gainers
Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.
CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session.
US Stocks Start Week On Lower Note, Dow Drops Over 100 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Monday.
JP Morgan Boosts Price Targets On These Casino Stocks
JP Morgan boosted the price target on Melco Resorts & Entertainment Limited (NASDAQ: MLCO) from $7 to $10. JP Morgan analyst Joseph Greff upgraded the stock from Neutral to Overweight. Melco Resorts & Entertainment shares rose 10.3% to trade at $7.27 on Monday.
Bitcoin Drops But Remains Above This Major Level; Curve DAO Token, Dogecoin Among Top Losers
Crypto prices started the week on a negative note, with Bitcoin (CRYPTO: BTC) trading lower on Monday. However, price for the most valued cryptocurrency in the world remained above the $16,000 level on Monday.
Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands
Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stock with a Buy rating. Reata Pharmaceuticals shares rose 1.9% to close at $36.03 on Friday.
BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 150 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.